Evidence map›Paper›PMID 32272224›Full record

ArticleBrain, behavior, and immunity2020

TNF-α and its soluble receptors mediate the relationship between prior severe mood episodes and cognitive dysfunction in euthymic bipolar disorder.

C E Millett, J Harder, J J Locascio, M Shanahan, G Santone, R N Fichorova, A Corrigan, C Baecher-Allan, K E Burdick

Open access · greenAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 4 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 4 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Secondary Mania induced by TNF-α inhibitors: A systematic review.Psychiatry and clinical neurosciences · 2022
    Pooled it
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Cognition in Bipolar Disorder: An Update for Clinicians.Focus (American Psychiatric Publishing) · 2023
    Review
  14. Review
  15. Review
  16. Anti-TNF-α Compounds as a Treatment for Depression.Molecules (Basel, Switzerland) · 2021
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

C E MillettMood and Psychosis Research Program, Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, United States; Department of Psychiatry, Harvard Medical School, Boston, MA, United States.
J HarderMood and Psychosis Research Program, Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, United States; Department of Psychiatry, Harvard Medical School, Boston, MA, United States.
J J LocascioMassachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital and Harvard Medical School, United States.
M ShanahanMood and Psychosis Research Program, Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, United States; Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital and Harvard Medical School, United States.
G SantoneLaboratory of Genital Tract Biology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
R N FichorovaLaboratory of Genital Tract Biology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
A CorriganMood and Psychosis Research Program, Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, United States.
C Baecher-AllanAnn Romney Center for Neurologic Disease, Harvard Medical School, Boston, MA 02115, USA; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
K E BurdickMood and Psychosis Research Program, Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, United States; Department of Psychiatry, Harvard Medical School, Boston, MA, United States. Electronic address: kburdick1@bwh.harvard.edu.
Brigham and Women's Hospital · USHarvard University · USMassachusetts General Hospital · US

Funding

Understanding the Neurocognitive Heterogeneity in Bipolar DisorderR01MH100125 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BURDICK, KATHERINE ELIZABETH · 2013 to 2017
$2.1M
NIMH NIH HHS R01 MH100125
6 · The paper itself

Abstract

backgroundBipolar disorder (BD) is one of the most disabling mental health conditions in the world. Symptoms of cognitive impairment in BD contribute directly to occupational and social deficiencies and are very difficult to treat. Converging evidence suggests that BD patients have increased peripheral markers of inflammation. The hypothesis of neuroprogression in BD postulates that cognitive deficits develop over the course of the illness and are influenced by prior severe mood episodes, leading to wear-and-tear on the brain- however, there exists a paucity of data statistically testing a mediating role of immune molecules in cognitive dysfunction in BD.

methodsThis is a cross-sectional study. We measured serum levels of tumor necrosis factor alpha (TNF-α), and soluble (s) TNF receptors one and two (sTNF-R1 and sTNF-R2) in 219 euthymic BD patients and 52 Healthy Controls (HCs). Structural equation modeling (SEM) was used for the primary purpose of assessing whether TNF markers (measured by the multiple indicators TNF-α, sTNF-R1 and sTNF-R2) mediate the effect or number of prior severe mood episodes (number of prior psychiatric hospitalizations) on cognitive performance.

resultsBD and HC groups did not differ on circulating levels of TNF molecules in the present study. However, we found higher sTNF-R1 concentration in 'late-stage' BD illness (>1 prior psychiatric hospitalization) compared to those in early stage illness. In the subsequent SEM, we found that the model fits the data acceptably (Chi-square = 49.2, p = 0.3), and had a 'close fit' (RMSEA = 0.02, PCLOSE = 0.9). Holding covariates constant (age, sex, premorbid IQ, education, and race), we found that the standardized indirect effect was significant, p = 0.015, 90%CI [-0.07, -0.01], indicating that the estimated model was consistent with peripheral TNF markers partially mediating a causal effect of severe mood episodes on executive function.

conclusionsOur results indicate that circulating levels of TNF molecules partially mediate the relationship between prior severe mood episodes and executive function in BD. These results may implicate TNF variables in the neuroprogressive course of BD and could point to novel interventions for cognition.

Indexed as

Bipolar DisorderCognitive DysfunctionCross-Sectional StudiesCyclothymic DisorderHumansTumor Necrosis Factor-alphaTumor Necrosis Factor-alphaCognitionEuthymiaInflammationMood disorder

Identifiers

PMID32272224
PMCPMC8577222
OpenAlexW3015725200

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.